Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
05/2011
05/04/2011CN101142180B Pyrrolidine derivatives as histamine h3 receptor antagonists
05/03/2011US7935833 Compound containing carboxylate ester and N2S2 ligand bi-functional groups and manufacturing method thereof
05/03/2011US7935832 Pyrrole and isoindole carboxamide derivatives as P2X7 modulators
05/03/2011CA2438480C Glucocorticoid receptor modulators
04/2011
04/28/2011WO2011050030A1 Alpha adrenergic receptor modulators
04/28/2011US20110098468 Nk1 antagonists
04/28/2011US20110098336 Pyrrolidin-2-one derivatives as androgen receptor modulator
04/28/2011US20110098334 Novel crystalline form of calcium zofenopril
04/28/2011US20110098319 Fatty acid derivatives for oral administration endowed with high palatability
04/28/2011US20110098309 Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds
04/28/2011US20110098302 Cyclic diaryl ether compounds as antagonists of prostaglandin d2 receptors
04/28/2011US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands
04/28/2011US20110098281 Benzenesulfonyl Compounds and the Use Thereof
04/28/2011US20110098276 Oxycarbamoyl compounds and the use thereof
04/28/2011US20110098221 INHIBITORS OF Akt ACTIVITY
04/28/2011US20110097735 Fluorescent pyrene compounds
04/28/2011CA2779298A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
04/28/2011CA2778423A1 Alpha adrenergic receptor modulators
04/27/2011EP2313412A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof
04/27/2011EP2313371A1 Process for preparing a 3-pyrrole substituted 2-indolinone malate salt
04/27/2011EP2313370A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
04/27/2011CN102036956A Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
04/27/2011CN102036955A Hydroxamate-based inhibitors of deacetylases b
04/27/2011CN102036953A Arylsulfonamide-based matrix metalloprotease inhibitors
04/27/2011CN102036936A Novel [F-18]-labelled l-glutamic acid and l-glutamine derivatives (II), use thereof and method for their production
04/27/2011CN102030783A One-dimensional micron or submicron material of metal organic platinum (II) coordination compounds and preparation method and application
04/27/2011CN102030700A Benzamide carboxylic acid compound as well as manufacturing method and medicinal application thereof
04/27/2011CN102030695A Method for preparing bactericide N-(2,4,6-trichlorophenyl) maleimide
04/27/2011CN102030653A Polymerizable compound
04/27/2011CN102029156A Process for preparing of [gamma]-butyrolactone and n-methyl pyrrolidone from 1,4-butanediol
04/27/2011CN101157650B Method for preparation of indole-1-methyl formate and its derivatives
04/26/2011US7932403 Process for preparing pyrrole derivatives and intermediates
04/26/2011US7932388 Intermediates of active esters for peptide synthesis, labeling, analysis; purity
04/26/2011US7932381 Process for producing carbapenem derivative and intermediate crystal therefor
04/26/2011US7932285 Compounds from Antrodia camphorata
04/26/2011US7932277 Peptide inhibitors of hepatitis C virus replication
04/26/2011CA2546970C Imidazole derivatives, processes for preparing them and their uses
04/26/2011CA2446778C Process for preparing polyisocyanates
04/26/2011CA2400871C Novel malconic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
04/26/2011CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
04/26/2011CA2322194C Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
04/21/2011WO2011047192A2 Protected amine labels and use in detecting analytes
04/21/2011WO2011047190A1 Gamma amino acid building blocks
04/21/2011WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses
04/21/2011WO2011046597A2 Biomarkers for the detection of breast cancer
04/21/2011WO2011046007A1 Process for preparation of diethylenetriaminepentaacetic acid derivatives, and diethylenetriaminepentaacetic acid derivatives
04/21/2011WO2011045259A1 Aminopropenoates as fungicides
04/21/2011WO2011045257A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
04/21/2011US20110092683 Phosphonium salts derivatives and uses thereof
04/21/2011US20110092559 Pyrrole and pyrazole daao inhibitors
04/21/2011US20110092557 Neuraminidase Inhibitors And Compositions And Methods Related Thereto
04/21/2011US20110092368 2,4,6-Phenyl-substituted cyclic ketoenols
04/21/2011CA2774512A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
04/21/2011CA2774250A1 C-linked hydroxamic acid derivatives useful as antibacterial agents
04/20/2011EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
04/20/2011EP2311804A2 Method for preparing n-substituted maleimides
04/20/2011EP2311803A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
04/20/2011EP2311802A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
04/20/2011EP2311451A1 Amino-methyl substituted tetracycline compounds
04/20/2011EP2310362A1 Formation of 18f and 19f fluoroarenes bearing reactive functionalities
04/20/2011EP2310361A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
04/20/2011EP2310360A1 Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives
04/20/2011EP1889834B1 Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
04/20/2011EP1720872B1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
04/20/2011EP1517908B1 Novel benzimidazole derivatives
04/20/2011EP1505963B1 Hepatitis c virus inhibitors
04/20/2011CN1910147B Malononitrile compound and use thereof
04/20/2011CN1902194B Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methyl)-pyrrol-1-yl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid
04/20/2011CN102026970A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
04/20/2011CN102026969A Novel N-(2-amino-phenyl)-acrylamides
04/20/2011CN102026961A Amide compound
04/20/2011CN102023483A Photoresist composition
04/20/2011CN101602703B Pyrrole group-containing compound and preparation method and application thereof
04/20/2011CN101462996B Preparation of 4-cyclohexyl proline derivative
04/20/2011CN101094860B Metal complex compound and organic electroluminescent element using the same
04/19/2011US7928228 Triazolone derivatives
04/19/2011US7928037 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
04/19/2011CA2498851C Heterocyclocarboxamide derivatives
04/16/2011CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
04/14/2011WO2011044229A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators
04/14/2011WO2011044225A1 Modulators of g protein-coupled receptor 88
04/14/2011WO2011044073A1 Pyrrolidine gpr40 modulators
04/14/2011WO2011044057A1 Sulfonamido pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
04/14/2011WO2011043480A1 Homocysteine synthase inhibitor
04/14/2011WO2011042765A1 Inorganic salt complexes of vildagliptin
04/14/2011WO2011042654A1 P-glycoprotein-specific non-competitive peptide and peptidomimetic modulators
04/14/2011WO2011042477A1 Substituted pyrroles and imidazoles as estrogen receptor ligands
04/14/2011WO2011042473A2 Novel estrogen receptor ligands
04/14/2011US20110086879 Carboxamide compounds and their use as calpain inhibitors
04/14/2011US20110086854 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
04/14/2011US20110086822 Substituted Tetracycline Compounds
04/14/2011US20110086409 Surfactant-Based Monolithic Columns, Methods for Making the Same, and Method for Using the Same
04/14/2011US20110086369 Fluorescent compounds for the diagnosis of infections, production method, and applications thereof
04/14/2011CA2777041A1 Pyrrolidine gpr40 modulators
04/14/2011CA2776260A1 P-glycoprotein-specific non-competitive peptide and peptidomimetic modulators
04/14/2011CA2776005A1 Inorganic salt complexes of vildagliptin
04/13/2011EP2308838A1 Nitrogen-containing aromatic heterocyclyl compound
04/13/2011EP2308812A2 N-acylsulfonamide apoptosis promoters
04/13/2011EP2307017A1 Compounds which can be used for the treatment of cancers
04/13/2011EP1140085B1 Azabicycloalkanes as ccr5 modulators
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 404